Loading...
Please wait, while we are loading the content...
Similar Documents
Muscarinc Receptor Antagonsts
| Content Provider | Semantic Scholar |
|---|---|
| Author | Hagenah, Jeffrey A. Shelley Eberle |
| Copyright Year | 2017 |
| Abstract | Expert Opinion, Advances in the management of chronic obstruc tive pulmonary disease, Tomasz M. Ziedalski et al 2003.* U.S. Appl. No. 10/992,927. Not yet published, Mammen et al. U.S. Appl. No. 1 1/077,222. Not yet published, Mammen et al. U.S. Appl. No. 1 1/077.433, Not yet published, Mammen et al. U.S. Appl. No. 1 1/077,224. Not yet published, Mammen et al. U.S. Appl. No. 1 1/076,631. Not yet published, Mammen et al. U.S. Appl. No. 1 1/077,436, Not yet published, Mammen et al. U.S. Appl. No. 1 1/077,349. Not yet published, Mammen et al. U.S. Appl. No. 1 1/077.345. Not yet published, Mammen et al. Broadley et al., “Muscarinic Receptor Agonists and Antagonists'. Molecules, 6, pp. 142-193 (2001). Eglen et al., “Muscarinic Receptor Subtypes: Pharmacology and Therapeutic Potential”. DN&P 10(8), pp. 462-469 (1997). Zlotos et al., “Muscarinic receptor agonists and antagonists'. Exp. Opin. Ther. Patents, 9(8), pp. 1029-1053 (1999). Naito et al., “Selective Muscarinic Antagonist. II.” Synthesis and Antimuscarinic Properties of Biphenylylcarbamate Derivatives, Chem. Pharm. Bull., vol. 46, No. 8, pp. 1286-1294 (1998). |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://patentimages.storage.googleapis.com/1b/b2/86/dd5fae6a51f7ce/US7265133.pdf |
| Alternate Webpage(s) | https://patentimages.storage.googleapis.com/d4/d8/9f/50aa76d5abc959/US7361648.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
